Abstract
Retinopathy of Prematurity (ROP) is a vasoproliferative disease of the retina in premature infants that can progress to blindness. Clinical ROP management standards have been established by seminal studies such as the Cryotherapy for ROP (CRYO-ROP) and Early Treatment for ROP (ET-ROP) trials, and have significantly decreased the incidence of poor visual outcomes in ROP. However, ROP continues to be a leading cause of childhood blindness worldwide.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
